Neuroendocrine, metabolic and pharmacological control of feeding behaviour--closing in on antiobesity treatment.
Vaag
Allan
A
D000818:Animals; D001067:Appetite Depressants / Q000627:therapeutic use; D001069:Appetite Regulation / Q000187:drug effects / Q000502:physiology; D002490:Central Nervous System / Q000187:drug effects / Q000503:physiopathology; D005247:Feeding Behavior / Q000187:drug effects* / Q000502:physiology*; D052216:Glucagon-Like Peptide 1 / Q000502:physiology; D006801:Humans; D007031:Hypothalamus / Q000187:drug effects / Q000503:physiopathology; D009490:Neurosecretory Systems / Q000503:physiopathology; D009765:Obesity / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology*; D019894:Peptide YY / Q000502:physiology
D001067:Appetite Depressants; D019894:Peptide YY; D052216:Glucagon-Like Peptide 1